The Role and Application of NGS Diagnostic Reports to Guide Immunotherapy-Based Interventions in Prostate Cancer
Presented by:
Johann de Bono, MD
Regius Professor of Cancer Research
Professor of Experimental Cancer Medicine and Honorary Consultant in Medical Oncology
Head of Division of Clinical Studies
Director of Drug Development Unit and Head of Prostate Cancer Targeted Therapy Group
ICR | Royal Marsden NHS Foundation Trust
Surrey, United Kingdom
Published
July 26, 2019
Created by
